BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 12168086)

  • 1. Role of the orphan nuclear receptor ROR alpha in the control of the metastatic behavior of androgen-independent prostate cancer cells.
    Moretti RM; Montagnani Marelli M; Motta M; Limonta P
    Oncol Rep; 2002; 9(5):1139-43. PubMed ID: 12168086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of the orphan nuclear receptor RORalpha counteracts the proliferative effect of fatty acids on prostate cancer cells: crucial role of 5-lipoxygenase.
    Moretti RM; Montagnani Marelli M; Sala A; Motta M; Limonta P
    Int J Cancer; 2004 Oct; 112(1):87-93. PubMed ID: 15305379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of the orphan nuclear receptor RORalpha induces growth arrest in androgen-independent DU 145 prostate cancer cells.
    Moretti RM; Marelli MM; Motta M; Polizzi D; Monestiroli S; Pratesi G; Limonta P
    Prostate; 2001 Mar; 46(4):327-35. PubMed ID: 11241556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gonadotropin-releasing hormone agonists reduce the migratory and the invasive behavior of androgen-independent prostate cancer cells by interfering with the activity of IGF-I.
    Montagnani Marelli M; Moretti RM; Mai S; Procacci P; Limonta P
    Int J Oncol; 2007 Jan; 30(1):261-71. PubMed ID: 17143537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of integrin subunits in DU-145/AR prostate cancer cells.
    Nagakawa O; Akashi T; Hayakawa Y; Junicho A; Koizumi K; Fujiuchi Y; Furuya Y; Matsuda T; Fuse H; Saiki I
    Oncol Rep; 2004 Oct; 12(4):837-41. PubMed ID: 15375509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and activation of alpha v beta 3 integrins by SDF-1/CXC12 increases the aggressiveness of prostate cancer cells.
    Sun YX; Fang M; Wang J; Cooper CR; Pienta KJ; Taichman RS
    Prostate; 2007 Jan; 67(1):61-73. PubMed ID: 17034033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. All-trans retinoic acid is a ligand for the orphan nuclear receptor ROR beta.
    Stehlin-Gaon C; Willmann D; Zeyer D; Sanglier S; Van Dorsselaer A; Renaud JP; Moras D; Schüle R
    Nat Struct Biol; 2003 Oct; 10(10):820-5. PubMed ID: 12958591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The alpha 3 beta 1 integrin is involved in melanoma cell migration and invasion.
    Melchiori A; Mortarini R; Carlone S; Marchisio PC; Anichini A; Noonan DM; Albini A
    Exp Cell Res; 1995 Jul; 219(1):233-42. PubMed ID: 7628538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of the orphan nuclear receptor Rev-Erb alpha in adipocyte differentiation and function.
    Laitinen S; Fontaine C; Fruchart JC; Staels B
    Biochimie; 2005 Jan; 87(1):21-5. PubMed ID: 15733732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of the nuclear orphan receptor RORgamma during adipocyte differentiation of D1 and 3T3-L1 cells.
    Austin S; Medvedev A; Yan ZH; Adachi H; Hirose T; Jetten AM
    Cell Growth Differ; 1998 Mar; 9(3):267-76. PubMed ID: 9543393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of melatonin MT(1) and MT(2) receptors, and ROR alpha(1) receptor in transplantable murine Colon 38 cancer.
    Karasek M; Carrillo-Vico A; Guerrero JM; Winczyk K; Pawlikowski M
    Neuro Endocrinol Lett; 2002 Apr; 23 Suppl 1():55-60. PubMed ID: 12019353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate cancer cells-osteoblast interaction shifts expression of growth/survival-related genes in prostate cancer and reduces expression of osteoprotegerin in osteoblasts.
    Fizazi K; Yang J; Peleg S; Sikes CR; Kreimann EL; Daliani D; Olive M; Raymond KA; Janus TJ; Logothetis CJ; Karsenty G; Navone NM
    Clin Cancer Res; 2003 Jul; 9(7):2587-97. PubMed ID: 12855635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of platelet-type 12-lipoxygenase promotes tumor cell survival by enhancing alpha(v)beta(3) and alpha(v)beta(5) integrin expression.
    Pidgeon GP; Tang K; Cai YL; Piasentin E; Honn KV
    Cancer Res; 2003 Jul; 63(14):4258-67. PubMed ID: 12874035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the alpha 6, beta 1 and beta 4 integrin subunits, basement membrane organization and proteolytic capacities in low and high metastatic human colon carcinoma xenografts.
    Daémi N; Vallet T; Thomasset N; Jacquier MF; Zebda N; Doré JF; Sordat B; Rémy L
    Invasion Metastasis; 1995; 15(3-4):103-15. PubMed ID: 8621266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in the mechanisms of action and physiological functions of the retinoid-related orphan receptors (RORs).
    Jetten AM
    Curr Drug Targets Inflamm Allergy; 2004 Dec; 3(4):395-412. PubMed ID: 15584888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The fibroblast growth factor receptor-4 Arg388 allele is associated with prostate cancer initiation and progression.
    Wang J; Stockton DW; Ittmann M
    Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6169-78. PubMed ID: 15448004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The structural integrity of ROR alpha isoforms is mutated in staggerer mice: cerebellar coexpression of ROR alpha1 and ROR alpha4.
    Matysiak-Scholze U; Nehls M
    Genomics; 1997 Jul; 43(1):78-84. PubMed ID: 9226375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-8 confers androgen-independent growth and migration of LNCaP: differential effects of tyrosine kinases Src and FAK.
    Lee LF; Louie MC; Desai SJ; Yang J; Chen HW; Evans CP; Kung HJ
    Oncogene; 2004 Mar; 23(12):2197-205. PubMed ID: 14767470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melatonin and prostate cancer cell proliferation: interplay with castration, epidermal growth factor, and androgen sensitivity.
    Siu SW; Lau KW; Tam PC; Shiu SY
    Prostate; 2002 Jul; 52(2):106-22. PubMed ID: 12111702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of hepatocyte growth factor on invasion of prostate cancer cell lines.
    Fujiuchi Y; Nagakawa O; Murakami K; Fuse H; Saiki I
    Oncol Rep; 2003; 10(4):1001-6. PubMed ID: 12792760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.